This paper is in the following e-collection/theme issue:

Viewpoints on Innovations in Cancer Care and Research (12) Skin Cancer and Melanoma Prevention (112) Chemotherapy and Side Effects Management (59) Clinical Cancer Research (83) Dermatology (45) Innovations and Technology in Cancer Care (423) Health Services Research in Oncology (35)

Published on in Vol 7, No 4 (2021): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29912, first published .
First-line Advanced Cutaneous Melanoma Treatments: Where Do We Stand?

First-line Advanced Cutaneous Melanoma Treatments: Where Do We Stand?

First-line Advanced Cutaneous Melanoma Treatments: Where Do We Stand?

Authors of this article:

Louay S Abdulkarim1 Author Orcid Image ;   Richard J Motley2 Author Orcid Image
Article Authors Cited by (4) Tweetations (6) Metrics

Journals

  1. Meevassana J, Anothaisatapon K, Subbalekha S, Kamolratanakul S, Siritientong T, Ruangritchankul K, Pungrasami P, Hamill K, Angsapatt A, Kitkumthorn N. BRAF V600E Immunohistochemistry Predicts Prognosis of Patients with Cutaneous Melanoma in Thai population. Plastic and Reconstructive Surgery - Global Open 2022;10(10):e4605 View
  2. Egeler M, van Leeuwen M, Fraterman I, van den Heuvel N, Boekhout A, Lai-Kwon J, Wilthagen E, Eriksson H, Haanen J, Wilgenhof S, Ascierto P, van Akkooi A, van de Poll-Franse L. Common toxicities associated with immune checkpoint inhibitors and targeted therapy in the treatment of melanoma: A systematic scoping review. Critical Reviews in Oncology/Hematology 2023;183:103919 View
  3. Frederiksen H, Ashwath M. Disseminated Melanoma: A Disappearing Left Ventricular Mass. CASE 2023;7(11):456 View
  4. Araghi M, Mannani R, Heidarnejad maleki A, Hamidi A, Rostami S, Safa S, Faramarzi F, Khorasani S, Alimohammadi M, Tahmasebi S, Akhavan-Sigari R. Recent advances in non-small cell lung cancer targeted therapy; an update review. Cancer Cell International 2023;23(1) View